Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Moorkens, Evelien
47  Ergebnisse:
Personensuche X
?
1

A Systematic Literature Review of Gaps and Challenges in Va..:

Moorkens, Evelien ; Lacosta, Teresa Barcina ; Dawoud, Dalia...
Value in Health.  26 (2023)  8 - p. 1137-1144 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Ciltacabtagene Autoleucel for Patients With Triple-class Ex..:

Delforge, Michel ; Vekemans, Marie-Christiane ; Depaus, Julien...
HemaSphere.  6 (2022)  12 - p. e813 , 2022
Link: https://doi.org/10.1097/..
 
?
3

How to balance valuable innovation with affordable access t..:

Simoens, Steven ; Abdallah, Khadidja ; Barbier, Liese...
Frontiers in Pharmacology.  13 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
4

Treatments in Patients with Relapsed/Refractory Multiple My..:

Delforge, Michel ; Vekemans, Marie-Christiane ; Anguille, Sébastien...
Transplantation and Cellular Therapy.  28 (2022)  3 - p. S6-S7 , 2022
Link: https://doi.org/10.1016/..
 
?
5

The Expiry of Humira® Market Exclusivity and the Entry of A..:

Moorkens, Evelien ; Godman, Brian ; Huys, Isabelle...
Frontiers in Pharmacology.  11 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
6

An overview of patents on therapeutic monoclonal antibodies..:

Moorkens, Evelien ; Vulto, Arnold G. ; Huys, Isabelle
mAbs.  12 (2020)  1 - p. , 2020
Link: https://doi.org/10.1080/..
 
?
7

A Look at the History of Biosimilar Adoption: Characteristi..:

Moorkens, Evelien ; Vulto, Arnold G. ; Kent, James...
BioDrugs.  35 (2020)  1 - p. 75-87 , 2020
Link: https://doi.org/10.1007/..
 
?
8

Economic evaluation of biosimilars for reimbursement purpos..:

Moorkens, Evelien ; Broux, Hannah ; Huys, Isabelle..
Journal of Market Access & Health Policy.  8 (2020)  1 - p. 1739509 , 2020
Link: https://doi.org/10.1080/..
 
?
9

Biosimilars in Belgium: a proposal for a more competitive m..:

Moorkens, Evelien ; Vulto, Arnold G. ; Huys, Isabelle
Acta Clinica Belgica.  76 (2020)  6 - p. 441-452 , 2020
Link: https://doi.org/10.1080/..
 
?
10

Learnings from Regional Market Dynamics of Originator and B..:

Moorkens, Evelien ; Barcina Lacosta, Teresa ; Vulto, Arnold G....
Pharmaceuticals.  13 (2020)  10 - p. 324 , 2020
Link: https://doi.org/10.3390/..
 
?
11

Uptake of Biosimilar Infliximab in the UK, France, Japan, a..:

Kim, Yujeong ; Kwon, Hye-Young ; Godman, Brian...
Frontiers in Pharmacology.  11 (2020)  - p. , 2020
Link: https://doi.org/10.3389/..
 
?
12

Different Policy Measures and Practices between Swedish Cou..:

Moorkens, Evelien ; Simoens, Steven ; Troein, Per...
BioDrugs.  33 (2019)  3 - p. 299-306 , 2019
Link: https://doi.org/10.1007/..
 
?
13

Different Policy Measures and Practices between Swedish Cou..:

Moorkens, Evelien ; Simoens, Steven ; Troein, Per...
BioDrugs.  33 (2019)  3 - p. 285-297 , 2019
Link: https://doi.org/10.1007/..
 
?
14

Policies for biosimilar uptake in Europe: An overview:

Moorkens, Evelien ; Vulto, Arnold G. ; Huys, Isabelle...
PLOS ONE.  12 (2017)  12 - p. e0190147 , 2017
Link: https://doi.org/10.1371/..
 
?
15

The Market of Biopharmaceutical Medicines: A Snapshot of a ..:

Moorkens, Evelien ; Meuwissen, Nicolas ; Huys, Isabelle...
Frontiers in Pharmacology.  8 (2017)  - p. , 2017
Link: https://doi.org/10.3389/..
 
1-15